Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitorsF Peyraud, J-P Guégan, D Bodet, et al.
British Journal of Cancer|November 4, 2015
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIsB Beuselinck, J Jean-Baptiste, G Couchy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2026
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?A Mavrikios, M Bortolot, C Le Péchoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1B Besse, E Felip, R Garcia Campelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)S Couraud, A B Cortot, L Greillier, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancerB Ricciuti, S Scalera, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT networkM Beau-Faller, N Prim, A-M Ruppert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapyA Cortellini, B Ricciuti, F Facchinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple InstitutionsM Aldea, L Zullo, V Levrat, et al.
Pageof 20